Source link : https://www.newshealth.biz/health-news/fda-oks-novel-levodopa-based-regimen-for-parkinsons/
The US Food and Drug Administration (FDA) has approved foscarbidopa and foslevodopa (Vyalev, AbbVie), a solution of carbidopa and levodopa prodrugs for 24-hour continuous subcutaneous infusion, for the treatment of motor fluctuations in adults with advanced Parkinson’s disease (PD). Due to the progressive nature of PD, “oral medications are eventually no longer as effective at […]
Author : News Health
Publish date : 2024-10-18 18:32:13
Copyright for syndicated content belongs to the linked Source.